Monday, March 27, 2017 9:56:34 AM
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 3,182,530 shares, a drop of 36.4% from the February 28th total of 5,004,312 shares. Approximately 4.8% of the company’s stock are short sold. Based on an average trading volume of 789,019 shares, the short-interest ratio is currently 4.0 days.
https://www.thecerbatgem.com/2017/03/27/short-interest-in-momenta-pharmaceuticals-inc-mnta-decreases-by-36-4.html
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM